AstraZeneca COVID-19 vaccine likely to protect for a year - CEO
BRUSSELS (Reuters) - AstraZeneca's potential coronavirus vaccine <AZN.L> is expected to protect against COVID-19 infection for about a year, the company's managing director told a Belgian radio station on Tuesday.
The British pharmaceutical company has already started trials on people developed by Oxford University. A Phase I study in the UK is expected to end soon and a Phase III study has already started, Pascal Soriot told Bel RTL.
"We believe it will protect for about a year," said Soriot.
AstraZeneca announced on Saturday that it had signed contracts with France, Germany, Italy and the Netherlands for the delivery of up to 400 million doses of the potential vaccine to the European Union.
Agreements have also been made with the United Kingdom and the United States.
"If everything goes well, we will have the results of the clinical studies in August / September. We will produce in parallel. We will be able to deliver from October if everything goes well," said Soriot.
(Reporting by Philip Blenkinsop; Editing by Jason Neely)
Watch the latest videos from Yahoo UK
You should check here to buy the best price guaranteed products.
Hawaii tourism roars & 'we can't find enough people to work': Lt. Governor
Biden mocked gun-rights advocates who say they need assault weapons to fight the government: 'You need F-15s and maybe some nuclear weapons'
Matt Gaetz’s Tweet About Defunding FBI Lasted Less Than A Minute Online
Everything You Need to Know About Butt Pimples (Like, How to Get Rid Of Them)
Voit's walk-off hit | FastCast
Pfizer says COVID vaccine highly effective against Delta variant